Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HYMN: A Randomized Controlled Phase III Trial Comparing Hyperthermia Plus Mitomycin to a Second Course of Bacillus Calmette-Guerin or Standard Therapy in Patients With Recurrence of Non-Muscle Invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guerin Therapy

NCT01094964 is registered in ClinicalTrials.gov with Cancer Research Campaign Clinical Trials Centre as lead sponsor.

NCT NCT01094964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01094964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HYMN: A Randomized Controlled Phase III Trial Comparing Hyperthermia Plus Mitomycin to a Second Course of Bacillus Calmette-Guerin or Standard Therapy in Patients With Recurrence of Non-Muscle Invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guerin Therapy
Lead sponsor
Cancer Research Campaign Clinical Trials Centre
Phase
Phase 3
Overall status
Unknown status
Start date
October 31, 2009
Completion date
Not reported
Enrollment
242 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer